Plant Comparison

Black Cohosh vs Goldenseal

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant ABlack CohoshActaea racemosaRanunculaceaeFull monograph →
Plant BGoldensealHydrastis canadensisRanunculaceaeFull monograph →

At a glance

Black Cohosh and Goldenseal: both belong to the Ranunculaceae family.

Black CohoshGoldenseal
Constituents21
Pharmacological actions14
Indicated uses79
Safety notes32
Cited sources2320
Indicated uses
Only Black Cohosh
AnxietyCancer (anticancer research)Low mood / depressionHot flashesMenopauseMenstrual crampsPMS / premenstrual syndrome
Shared (0)
none
Only Goldenseal
Arthritis / joint painBloatingDiarrhoeaIndigestionInfection (general)Inflammation (general)Skin irritationSore throatWounds
Pharmacological actions
Only Black Cohosh
Anticancer (preclinical)
Shared (0)
none
Only Goldenseal
Anti-inflammatoryAntimicrobialAstringentDigestive aid

Key Constituents

Triterpene glycosides (actein, 23-epi-26-deoxyactein/cimicifugoside)[2, 7, 8]

The compounds to which standardised extracts are normalised; act without measurable systemic oestrogenic effect.

Triterpene saponinsGlycosidesTerpenes / terpenoids
Phenolic acids (fukinolic and cimicifugic acids)[7]

Antioxidant constituents of the root.

Phenolic acids
Isoquinoline alkaloids - berberine (principal), hydrastine and canadine[1, 4, 12]

Berberine is the main antimicrobial, hypoglycaemic and hypolipidaemic constituent. Notably, whole-leaf extracts are more potent against MRSA than isolated berberine (owing to efflux-pump-inhibitory flavonoids) and show quorum-quenching, anti-virulence activity.

FlavonoidsAlkaloidsBerberine

Pharmacological Actions

Anticancer (preclinical)[12, 13, 14, 15]

Black cohosh (Actaea racemosa) extracts and the triterpene glycoside actein inhibit proliferation of human breast, colon and liver cancer cells and potentiate chemotherapy (preclinical).

Anti-inflammatory[1]

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)

Antimicrobial[1, 2, 3, 4, 5, 6, 12]

Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat

Astringent[1]

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth)

Digestive aid[1, 5]

Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)

Traditional & Indicated Uses

Anxiety[7, 16, 17]Strong · 9/10

Reduces neurovegetative and psychological menopausal symptoms (including anxiety and low mood)

Evidence: 9
Label: Anxiety
Cancer (anticancer research)[12, 13, 14, 15]Traditional · 2/10

Ethanolic black cohosh extract inhibits growth of MCF-7 and MDA-MB-231 breast cancer cells; actein induces apoptosis/G1 arrest, inhibits breast, colon and HepG2 liver cancer cell growth and synergizes with doxorubicin, 5-FU, paclitaxel and simvastatin (preclinical).

Evidence: 2
Label: Cancer (anticancer research)
Low mood / depression[7, 16, 17]Strong · 9/10

Reduces neurovegetative and psychological menopausal symptoms (including anxiety and low mood)

Evidence: 9
Label: Low mood / depression
Hot flashes[1, 3, 4, 6, 7, 16, 18, 19, 20, 21]Strong · 10/10

Relief of menopausal symptoms - hot flashes, sweating, sleep and mood disturbance (a meta-analysis supports benefit, though an earlier systematic review judged the evidence inconsistent)

Evidence: 10
Label: Hot flashes
Menopause[1, 2, 3, 4, 5, 6, 7, 16, 17, 18, 19, 20, 21]Strong · 10/10

Reduces neurovegetative and psychological menopausal symptoms (including anxiety and low mood); Relief of menopausal symptoms - hot flashes, sweating, sleep and mood disturbance (a meta-analysis supports benefit, though an earlier systematic review judged the evidence inconsistent)

Evidence: 10
Label: Menopause
Menstrual cramps[7]Good · 7/10

Premenstrual and menstrual complaints (traditional use)

Evidence: 7
Label: Menstrual cramps
PMS / premenstrual syndrome[7]Good · 7/10

Premenstrual and menstrual complaints (traditional use)

Evidence: 7
Label: PMS / premenstrual syndrome
Arthritis / joint pain[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Arthritis / joint pain
Bloating[1]Moderate · 5/10

inferred from digestive action

Evidence: 5
Label: Bloating
Diarrhoea[1]Moderate · 5/10

inferred from astringent action

Evidence: 5
Label: Diarrhoea
Indigestion[1]Moderate · 5/10

Digestive / gastrointestinal support (traditional for dyspepsia and ulcers)

Evidence: 5
Label: Indigestion
Infection (general)[1, 4, 12]Moderate · 5/10

Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat; Topical for skin infections and irritation - whole-leaf extract is active in vitro against methicillin-resistant Staphylococcus aureus (MRSA)

Evidence: 5
Label: Infection (general)
Inflammation (general)[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Inflammation (general)
Skin irritation[1]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation
Sore throat[1, 4, 12]Moderate · 5/10

Anti-inflammatory and astringent for inflamed mucous membranes (sore-throat gargle, mouth); Antimicrobial (berberine) - supports skin, mucosal and gastrointestinal infections and sore throat

Evidence: 5
Label: Sore throat
Wounds[1, 4, 12]Moderate · 5/10

inferred from antimicrobial action

Evidence: 5
Label: Wounds

Safety, Cautions & Contraindications

Safety note[7, 16]Serious

Rare reports of liver injury have prompted a precaution; large meta-analytic data found no evidence of hepatotoxicity, but stop use and seek advice if signs of liver problems occur (jaundice, dark urine, upper-abdominal pain).

Safety note[8]Info

Current evidence does not show an increased risk of breast cancer or proliferation of oestrogen-sensitive tissue, but women with or at risk of hormone-sensitive cancer should use it only under medical guidance.

Safety note[7]Caution

Not recommended during pregnancy or breastfeeding.

Safety note[1]Caution

Contraindicated in pregnancy and breastfeeding: berberine crosses the placenta and into milk and can cause or worsen newborn jaundice (risk of kernicterus); do not give to infants.

Safety note[1, 14]Caution

Berberine strongly inhibits drug-metabolising enzymes (especially CYP3A4 and CYP2D6), so it can raise the blood levels of many medicines - a significant herb-drug-interaction risk. In a screen of commercial herbal products, goldenseal was among the most potent CYP2D6 inhibitors and also inhibited CYP3A4. High doses have shown possible liver, nerve and photo-toxicity.

External Ids

Gbif: 6376106
Wikidata: Q682257
Gbif: 3033110
Wikidata: Q1051710

Botanical Description

Tall, woodland perennial herb rising from a thick, knotty, dark rhizome with wiry black roots. The leaves are large and compound (2-3-ternately divided), with sharply toothed, oval to lance-shaped leaflets. In summer it sends up tall, wand-like racemes of small, unpleasant-smelling white flowers held well above the foliage, giving rise to the old name 'bugbane'; the flowers lack petals and consist mainly of a fluffy cluster of white stamens.[2]

Height: 1-2.5 m (flowering stems)
Habit: Tall, rhizomatous, woodland perennial herb
Leaves: Large, 2-3-ternately compound, with sharply toothed oval to lance-shaped leaflets
Flowers: Small, malodorous, petal-less white flowers with fluffy stamens in tall wand-like racemes
Stem: Tall, erect flowering stem well above the basal foliage
Root: Thick, knotty, dark rhizome with numerous wiry black roots
Fruit: Dry, follicle-like seed pods
Flowering Period: Summer (June-September)

Low, woodland perennial herb rising from a knotted, bright yellow rhizome with wiry yellow roots. Each stem bears two ragged, palmately lobed, maple-like leaves and a single small, inconspicuous greenish-white flower, followed by a raspberry-like cluster of red berries.[1]

Height: 15-30 cm
Habit: Low, woodland perennial herb
Leaves: Two per stem, ragged, palmately lobed, maple-like
Flowers: Single, small, inconspicuous, greenish-white, petal-less
Stem: Hairy, upright, bearing two leaves
Root: Knotted, bright yellow rhizome with wiry yellow roots (the medicinal part)
Fruit: Raspberry-like cluster of red berries
Flowering Period: April-May

Habitat

Native to rich, shaded deciduous woodland and woodland margins of eastern North America, from southern Canada to Georgia, typically on moist, humus-rich soils.[2]

Grows in rich, shaded deciduous woodland with humus-rich soil; native to eastern North America, now scarce in the wild due to overharvesting and largely supplied by cultivation.[1]

Harvesting

The root and rhizome are dug in autumn, after the seeds have ripened and the foliage has died back and the plant's energy has returned to the rootstock; the rhizome is cleaned, cut and dried.[2]

Parts: Root and rhizome
Season: Autumn

The rhizome and root are dug in autumn from plants at least three to four years old, when berberine content is highest, then cleaned and dried; because wild populations are depleted, cultivated or sustainably sourced material is strongly preferred, and careful identification against the toxic mayapple and bloodroot, which share its woodland habitat, is essential before any wild-harvesting.[1]

Parts: Rhizome and root
Season: Autumn, from mature (3-4+ year) plants

Traditional Uses

Black cohosh root was used by Native American peoples for gynaecological complaints, rheumatism and general malaise, and entered nineteenth-century Eclectic medicine as a remedy for menstrual and menopausal disorders. It remains best known today as a standardised extract for menopausal hot flashes, night sweats and mood disturbance.[2, 6]

Goldenseal root has a Native American and, after adoption by Eclectic physicians, wider North American tradition as a bitter tonic and antimicrobial remedy for mucous-membrane infections, sore throat, digestive upset and topical skin infections, directly reflecting its high berberine content.[1]

Preparations

Standardised extract[2, 7]

Isopropanolic or ethanolic extracts of the dried root and rhizome, standardised to triterpene glycoside content, are the best-studied clinical form.

Decoction[2]

Traditional decoction of the dried, chopped root and rhizome.

Decoction[1]

Dried rhizome and root simmered in water as a traditional bitter antimicrobial tea, or used as a gargle for sore throat.

Tincture[13]

Tincture 1:10 in 60% ethanol of the dried rhizome and root, 2-4 ml three times daily per the WHO monograph Rhizoma Hydrastis. Educational reference only, not a prescription.

Standardised extract[4]

Extract standardised to berberine/hydrastine content, taken as capsules; whole-leaf extracts have shown stronger antimicrobial activity than isolated berberine in some studies.

Dosage

Standardised extract[7, 9, 10]

The WHO monograph on Rhizoma Cimicifugae Racemosae gives a daily dosage of 40-60% isopropyl alcohol or ethanol extracts of the crude drug corresponding to 40 mg of drug, which matches the extract dose used in clinical studies. Educational reference only, not a prescription.

Tincture (1:10)[11]

Health Canada's NNHPD monograph accepts a tincture among the methods of preparation for black cohosh and sets the dose as 40-2,400 mg of dried root and/or rhizome per day for adults 18 years and older; it states the quantity as dried-herb equivalent rather than a tincture volume. Neither the EU herbal monograph nor the WHO monograph gives a tincture posology - both specify standardised extract preparations only. Educational reference only, not a prescription.

Decoction/tincture[13]

The WHO monograph on Rhizoma Hydrastis gives a daily dose of 0.5-1.0 g of the dried rhizome and root three times, or taken as a decoction; a 1:1 liquid extract in 60% ethanol at 0.3-1.0 mL three times; or a 1:10 tincture in 60% ethanol at 2-4 mL three times. For short-term use only, given goldenseal's potent CYP-enzyme inhibition and its contraindication in pregnancy. Educational reference only, not a prescription.

References

REF-2397, REF-2398, REF-2399, REF-2400, REF-2401, REF-2589
REF-0455, REF-1849, REF-1850, REF-0588, REF-1851, REF-1852, REF-1853, REF-1854, REF-1855, REF-1856, REF-1857

Lookalikes Review

Outcome: has-lookalikes
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: has-lookalikes
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dangerous Lookalikes

Safety note[22, 23]Dangerous
Dangerous Plant: actaea-pachypoda
Confused Part: Woodland rhizome dug as black cohosh; toxic baneberries (doll's eye and red baneberry) share very similar foliage and rhizomes and are gathered in mistake for it.
Confusion Context: Black cohosh (Actaea racemosa) is dug for its rhizome, but several related North American Actaea species - notably doll's eye (Actaea pachypoda) and red baneberry (Actaea rubra) - have very similar woodland foliage and rhizomes and are easily mistaken for it during harvesting. Those baneberries are toxic in all parts: ingestion causes burning of the mouth, severe vomiting and diarrhoea and seizures, and red baneberry can be fatal, especially in children. Peer-reviewed work confirms commercial black cohosh is frequently adulterated with other Actaea species, contributing to safety concerns. Because the plants look alike - especially in spring before flowers or fruit appear - this is a genuine hazard.
Distinguishing Features: Fruit (decisive when present): black cohosh bears a tall wand of fluffy white flowers that ripens to dry, papery seed pods. Baneberries instead bear clusters of shiny berries - chalk-white with a black eye (doll's eye) or glossy red (red baneberry). Any fleshy berries mean baneberry, not black cohosh., Flower: black cohosh has long, showy white bottlebrush flower spikes; baneberry flowers are in short, rounded fluffy clusters., Vegetative caution: in spring the leaves alone are very similar (Actaea foliage), so do not dig by leaf alone - the species are separated mainly on flowers and fruit. Confirm the plant in flower or fruit, or buy authenticated black cohosh.
Key Test: Identify the plant in flower or fruit before digging. Black cohosh has tall white bottlebrush flower spikes that turn into dry papery pods; baneberry makes clusters of shiny white-with-black-dot or red berries. If you see fleshy berries - or cannot confirm flowers or fruit - do not dig the root; the baneberries are toxic. When in doubt, buy authenticated black cohosh.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Safety note[18, 19]Dangerous
Dangerous Plant: podophyllum-peltatum
Confused Part: Woodland rhizome dug as goldenseal; mayapple shares the same rich woods and has similar lobed, maple-like leaves.
Confusion Context: Goldenseal (Hydrastis canadensis) is dug from rich woodland for its yellow rhizome. Mayapple (Podophyllum peltatum) grows in the same rich-woods habitat and, once its leaves expand, its lobed maple-like leaves resemble goldenseal, so novice foragers confuse them. Mayapple contains podophyllotoxin (a potent cell poison) in all parts except the ripe fruit; ingestion causes severe vomiting and diarrhoea and can cause serious systemic toxicity. Because the plants share habitat and leaf shape, this is a genuine hazard when digging goldenseal.
Distinguishing Features: Whole plant: goldenseal has a hairy upright stem bearing usually two ragged, maple-like lobed leaves and a single small flower, with a knotted BRIGHT-YELLOW rhizome. Mayapple has one or two large, smooth, umbrella-like lobed leaves on a hairless stalk and a white flower nodding beneath, with a white-ish creeping rhizome., Rhizome colour (decisive): goldenseal's rhizome and root are vivid yellow inside (berberine). Mayapple's rhizome is not bright yellow., Leaf texture: goldenseal leaves are hairy and puckered; mayapple leaves are large, smooth and shield-like (the stalk joins near the centre).
Key Test: Dig only after matching the whole plant, and check the rhizome. A hairy stem with ragged maple-like leaves over a BRIGHT-YELLOW knotted rhizome = goldenseal. Large smooth umbrella-like leaves over a pale rhizome (no yellow) = mayapple - toxic, do not use. If the root is not bright yellow inside, do not use it.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Safety note[18, 20]Dangerous
Dangerous Plant: sanguinaria-canadensis
Confused Part: Woodland rhizome dug as goldenseal; bloodroot grows in the same rich woods and its rhizome is gathered in mistake for goldenseal.
Confusion Context: Bloodroot (Sanguinaria canadensis) shares the same rich-woods spring habitat as goldenseal and is listed among goldenseal's harvesting look-alikes. Bloodroot is a high-severity poison: its rhizome contains isoquinoline alkaloids (sanguinarine) and, when broken, oozes a bright red-orange sap; ingestion causes vomiting, faintness, dizziness, dilated pupils and, in serious cases, heart failure, and the sap is destructive to tissue. Because both are dug for their rhizomes from the same woodland, this is a genuine hazard.
Distinguishing Features: Sap colour (decisive): a broken bloodroot rhizome bleeds a bright RED-ORANGE sap. Goldenseal's rhizome is BRIGHT YELLOW inside, not red., Leaf: bloodroot has a single, rounded, deeply scalloped/lobed grey-green leaf that wraps the flower stalk, and a white flower; goldenseal has a hairy stem with two ragged maple-like leaves., Whole plant: confirm goldenseal by its paired hairy maple-like leaves and yellow root before digging.
Key Test: Break the rhizome and look at the sap and leaves. Bright YELLOW root with paired hairy maple-like leaves = goldenseal. A single scalloped leaf and a rhizome bleeding RED-ORANGE sap = bloodroot - a high-severity poison, do not use. If the sap is red, it is not goldenseal.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Drug Class Interactions

Not documented

Safety note[15, 16]Caution
Drug Class: cyp3a4-substrates
Mechanism: Goldenseal's berberine and hydrastine strongly inhibit CYP3A4 (and also CYP2D6), enzymes that clear many medicines. In a controlled study in healthy volunteers, 28 days of goldenseal cut CYP3A4/5 and CYP2D6 activity by roughly 40%, so it can raise the blood levels and side effects of drugs handled by these pathways - for example some statins, calcium-channel blockers and sedatives (CYP3A4), and certain antidepressants, beta-blockers and opioids (CYP2D6). Separate dosing and monitor, or avoid combining with narrow-margin medicines.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[17]Caution
Drug Class: antidiabetics
Mechanism: Goldenseal is rich in berberine, its main alkaloid, which lowers blood glucose - meta-analyses of randomised trials show berberine significantly reduces fasting glucose and HbA1c. Taken with diabetes medicines, goldenseal may therefore add to blood-sugar lowering, so monitor blood glucose.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

References & Sources

  1. Hedaoo, K. and Badge, A.K. and Tiwade, Y.R. and Bankar, N.J. and Mishra, V.H (2024) 'Exploring the Efficacy and Safety of Black Cohosh (Actaea racemosa) in Menopausal Symptom Management', Journal of Mid-life Health, 15(1), pp. 5-11. doi:10.4103/jmh.jmh_242_23 Meta-analysis / review
    https://doi.org/10.4103/jmh.jmh_242_23
  2. Salari, S. and Amiri, M.S. and Ramezani, M. and Moghadam, A.T. and Elyasi, S. and Sahebkar, A. and Emami, S.A (2021) 'Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review', Advances in Experimental Medicine and Biology, 1308, pp. 403-449. doi:10.1007/978-3-030-64872-5_24 Meta-analysis / review
    https://doi.org/10.1007/978-3-030-64872-5_24
  3. Drewe, J. and Boonen, G. and Culmsee, C (2022) 'Treat more than heat - New therapeutic implications of Cimicifuga racemosa through AMPK-dependent metabolic effects', Phytomedicine, 100, pp. 154060. doi:10.1016/j.phymed.2022.154060 Meta-analysis / review
    https://doi.org/10.1016/j.phymed.2022.154060
  4. Curtis, S. and Moore, A. and Breakspear, I (2026) 'Efficacy and safety of Actaea racemosa for relieving climacteric complaints', Menopause, 33(5), pp. 624-631. doi:10.1097/GME.0000000000002704 Meta-analysis / review
    https://doi.org/10.1097/GME.0000000000002704
  5. Beer, A.M. and Neff, A (2013) 'Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints', Evidence-Based Complementary and Alternative Medicine, 2013, pp. 860602. doi:10.1155/2013/860602 Meta-analysis / review
    https://doi.org/10.1155/2013/860602
  6. Mohapatra, S., Iqubal, A., Ansari, M.J., Jan, B., Zahiruddin, S., Mirza, M.A., Ahmad, S. and Iqbal, Z (2022) 'Benefits of Black Cohosh (Cimicifuga racemosa) for Women Health: An Up-Close and In-Depth Review', Pharmaceuticals, 15(3), pp. 278. doi:10.3390/ph15030278 Clinical study
    https://doi.org/10.3390/ph15030278
  7. Castelo-Branco, C., Gambacciani, M., Cano, A., Minkin, M.J., Rachon, D., Ruan, X., Beer, A.M., Schnitker, J., Henneicke-von Zepelin, H.H. and Pickartz, S (2020) 'Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence', Climacteric. doi:10.1080/13697137.2020.1820477 Meta-analysis / review
    https://doi.org/10.1080/13697137.2020.1820477
  8. Fritz, H., Seely, D., McGowan, J., Skidmore, B., Fernandes, R., Kennedy, D.A., Cooley, K., Wong, R., Sagar, S., Balneaves, L.G. and Fergusson, D (2013) 'Black cohosh and breast cancer: a systematic review', Integrative Cancer Therapies. doi:10.1177/1534735413477191 Meta-analysis / review
    https://doi.org/10.1177/1534735413477191
  9. European Medicines Agency (HMPC) (2018) 'European Union herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizoma, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf
  10. World Health Organization (2002) 'Rhizoma Cimicifugae Racemosae'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
    https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37
  11. Health Canada, Natural and Non-prescription Health Products Directorate (2026) 'Natural Health Product Monograph: Black Cohosh - Actaea racemosa'. Available at: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_black-cohosh_english.pdf Traditional / reference
    https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_black-cohosh_english.pdf
  12. Einbond, L.S. and Shimizu, M. and Nuntanakorn, P. and Seter, C. and Cheng, R. and Jiang, B. and Kronenberg, F. and Kennelly, E.J. and Weinstein, I.B (2006) 'Actein and a fraction of black cohosh potentiate antiproliferative effects of chemotherapy agents on human breast cancer cells', Planta Medica, 72(13), pp. 1200-1206. doi:10.1055/s-2006-947225 Preclinical
    https://doi.org/10.1055/s-2006-947225
  13. Rice, S. and Amon, A. and Whitehead, S.A (2006) 'Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells', Maturitas, 56(4), pp. 359-367. doi:10.1016/j.maturitas.2006.10.002 Preclinical
    https://doi.org/10.1016/j.maturitas.2006.10.002
  14. Einbond, L.S. and Soffritti, M. and Degli Esposti, D. and Wu, H.-A. and Balick, M. and Ma, H. and Redenti, S. and Roter, A (2018) 'A transcriptomic analysis of black cohosh: Actein alters cholesterol biosynthesis pathways and synergizes with simvastatin', Food and Chemical Toxicology, 120, pp. 356-366. doi:10.1016/j.fct.2018.06.064 Preclinical
    https://doi.org/10.1016/j.fct.2018.06.064
  15. Einbond, L.S. and Soffritti, M. and Degli Esposti, D. and Park, T. and Cruz, E. and Su, T. and Wu, H.-A. and Wang, X. and Zhang, Y.-J. and Ham, J. and Goldberg, I.J. and Kronenberg, F. and Vladimirova, A (2009) 'Actein activates stress- and statin-associated responses and is bioavailable in Sprague-Dawley rats', Fundamental and Clinical Pharmacology, 23(3), pp. 311-321. doi:10.1111/j.1472-8206.2009.00673.x Preclinical
    https://doi.org/10.1111/j.1472-8206.2009.00673.x
  16. Castelo-Branco, C., Gambacciani, M., Cano, A., Minkin, M.J., Rachon, D., Ruan, X., Beer, A.M., Schnitker, J., Henneicke-von Zepelin, H.H. and Pickartz, S (2020) 'Review and meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence', Climacteric, 24(2), pp. 109--119. doi:10.1080/13697137.2020.1820477 Meta-analysis / review
    https://doi.org/10.1080/13697137.2020.1820477
  17. Shahmohammadi, A., Ramezanpour, N., Mahdavi Siuki, M., Dizavandi, F., Ghazanfarpour, M., Rahmani, Y., Tahajjodi, R. and Babakhanian, M (2019) 'The efficacy of herbal medicines on anxiety and depression in peri- and postmenopausal women: A systematic review and meta-analysis', Post Reproductive Health, 25(3), pp. 131--141. doi:10.1177/2053369119841166 Meta-analysis / review
    https://doi.org/10.1177/2053369119841166
  18. Borrelli, F. and Ernst, E (2008) 'Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy', Pharmacological Research, 58(1), pp. 8--14. doi:10.1016/j.phrs.2008.05.008 Meta-analysis / review
    https://doi.org/10.1016/j.phrs.2008.05.008
  19. Pokushalov, E., Ponomarenko, A., Garcia, C., Kasimova, L., Pak, I., Shrainer, E., Romanova, A., Kudlay, D., Johnson, M. and Miller, R (2025) 'Assessing the combined effects of Black Cohosh, Soy Isoflavones, and SDG Lignans on menopausal symptoms: a randomized, double-blind, placebo-controlled clinical trial', European Journal of Nutrition, 64(3). doi:10.1007/s00394-025-03588-y Randomized trial
    https://doi.org/10.1007/s00394-025-03588-y
  20. Tanmahasamut, P., Vichinsartvichai, P., Rattanachaiyanont, M., Techatraisak, K., Dangrat, C. and Sardod, P (2014) 'Cimicifuga racemosa extract for relieving menopausal symptoms: a randomized controlled trial', Climacteric, 18(1), pp. 79--85. doi:10.3109/13697137.2014.933410 Randomized trial
    https://doi.org/10.3109/13697137.2014.933410
  21. Pockaj, B.A., Gallagher, J.G., Loprinzi, C.L., Stella, P.J., Barton, D.L., Sloan, J.A. and others (2006) 'Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1', Journal of Clinical Oncology, 24(18), pp. 2836--2841. doi:10.1200/JCO.2005.05.4296 Randomized trial
    https://doi.org/10.1200/JCO.2005.05.4296
  22. United Plant Savers 'Distinguishing Black Cohosh from Look-Alikes'. Available at: https://unitedplantsavers.org/distinguishing-black-cohosh-from-look-alikes/ Traditional / reference
    https://unitedplantsavers.org/distinguishing-black-cohosh-from-look-alikes/
  23. Jiang, B. and Ma, C. and Motley, T. and Kronenberg, F. and Kennelly, E.J (2011) 'Phytochemical fingerprinting to thwart black cohosh adulteration: a 15 Actaea species analysis', Phytochemical Analysis, 22(4), pp. 339-51. doi:10.1002/pca.1285 Preclinical
    https://doi.org/10.1002/pca.1285
  1. Mandal, S.K., Maji, A.K., Mishra, S.K., Ishfaq, P.M., Devkota, H.P., Silva, A.S. and Das, N (2020) 'Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues', Pharmacological Research. doi:10.1016/j.phrs.2020.105085 Randomized trial
    https://doi.org/10.1016/j.phrs.2020.105085
  2. Corn, J., Tibbitts, D., Ito, H., Schafer, M. and Vasilevsky, N (2021) 'Effects of Hydrastis Canadensis, Commiphora Habessinica, Phytolacca Americana, and Echinacea Purpurea on Bacterial Growth', Alternative Therapies in Health and Medicine, 27(4), pp. 24-27. Preclinical
    https://scholar.google.com/scholar?q=Effects%20of%20Hydrastis%20Canadensis%2C%20Commiphora%20Habessinica%2C%20Phytolacca%20Americana%2C%20and%20Echinacea%20Purpurea%20on%20Bacterial%20Growth
  3. Ettefagh, K.A., Burns, J.T., Junio, H.A., Kaatz, G.W. and Cech, N.B (2010) 'Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition', Planta Medica, 77(8), pp. 835-840. doi:10.1055/s-0030-1250606 Preclinical
    https://doi.org/10.1055/s-0030-1250606
  4. Cech, N.B., Junio, H.A., Ackermann, L.W., Kavanaugh, J.S. and Horswill, A.R (2012) 'Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA)', Planta Medica, 78(14), pp. 1556--1561. doi:10.1055/s-0032-1315042 Traditional / reference
    https://doi.org/10.1055/s-0032-1315042
  5. Mahady, G.B., Pendland, S.L., Stoia, A. and Chadwick, L.R (2003) 'In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis', Phytotherapy Research, 17(3), pp. 217-221. doi:10.1002/ptr.1108 Preclinical
    https://doi.org/10.1002/ptr.1108
  6. Junio, H.A., Sy-Cordero, A.A., Ettefagh, K.A., Burns, J.T., Micko, K.T., Graf, T.N., Richter, S.J., Cannon, R.E., Oberlies, N.H. and Cech, N.B (2011) 'Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)', Journal of Natural Products, 74(7), pp. 1621-1629. doi:10.1021/np200336g Preclinical
    https://doi.org/10.1021/np200336g
  7. Britton, E.R., Kellogg, J.J., Kvalheim, O.M. and Cech, N.B (2017) 'Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal)', Journal of Natural Products, 81(3), pp. 484-493. doi:10.1021/acs.jnatprod.7b00654 Preclinical
    https://doi.org/10.1021/acs.jnatprod.7b00654
  8. Leyte-Lugo, M., Britton, E.R., Foil, D.H., Brown, A.R., Todd, D.A., Rivera-Chavez, J., Oberlies, N.H. and Cech, N.B (2017) 'Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis)', Phytochemistry Letters, 20, pp. 54-60. doi:10.1016/j.phytol.2017.03.012 Preclinical
    https://doi.org/10.1016/j.phytol.2017.03.012
  9. Gurley, B.J., Swain, A., Hubbard, M.A., Hartsfield, F., Thaden, J., Williams, D.K., Gentry, W.B. and Tong, Y (2007) 'Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo', Clinical Pharmacology and Therapeutics, 83(1), pp. 61-69. doi:10.1038/sj.clpt.6100222 Randomized trial
    https://doi.org/10.1038/sj.clpt.6100222
  10. Wallace, E.D., Oberlies, N.H., Cech, N.B. and Kellogg, J.J (2018) 'Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics', Food and Chemical Toxicology, 120, pp. 439-447. doi:10.1016/j.fct.2018.07.033 Preclinical
    https://doi.org/10.1016/j.fct.2018.07.033
  11. Douglas, J.A., Follett, J.M., Parmenter, G.A., Sansom, C.E., Perry, N.B. and Littler, R.A (2010) 'Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis', Fitoterapia, 81(7), pp. 925-928. doi:10.1016/j.fitote.2010.06.006 Preclinical
    https://doi.org/10.1016/j.fitote.2010.06.006
  12. Singh, S., Pathak, N., Fatima, E. and Negi, A.S (2021) 'Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine', European Journal of Medicinal Chemistry. doi:10.1016/j.ejmech.2021.113839 Preclinical
    https://doi.org/10.1016/j.ejmech.2021.113839
  13. World Health Organization (2007) 'Rhizoma Hydrastis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
    https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37
  14. Sevior, D.K., Hokkanen, J., Tolonen, A., Abass, K., Tursas, L., Pelkonen, O. and Ahokas, J.T (2010) 'Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail', Xenobiotica, 40(4), pp. 245--254. doi:10.3109/00498251003592683 Preclinical
    https://doi.org/10.3109/00498251003592683
  15. Gurley, B.J., Gardner, S.F., Hubbard, M.A., Williams, D.K., Gentry, W.B., Khan, I.A. and Shah, A (2005) 'In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes', Clinical Pharmacology and Therapeutics, 77(5), pp. 415-426. doi:10.1016/j.clpt.2005.01.009 Randomized trial
    https://doi.org/10.1016/j.clpt.2005.01.009
  16. McDonald, M.G., Tian, D.D., Thummel, K.E., Paine, M.F. and Rettie, A.E (2020) 'Modulation of major human liver microsomal cytochromes P450 by component alkaloids of goldenseal: time-dependent inhibition and allosteric effects', Drug Metabolism and Disposition, 48(10), pp. 1018-1027. doi:10.1124/dmd.120.091041 Preclinical
    https://doi.org/10.1124/dmd.120.091041
  17. Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., Zhang, C., Wang, Y. and Liu, W.J (2021) 'The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials', Oxidative Medicine and Cellular Longevity, 2021, pp. 2074610. doi:10.1155/2021/2074610 Meta-analysis / review
    https://doi.org/10.1155/2021/2074610
  18. Forest Farming (Cooperative Extension) 'Goldenseal (Hydrastis canadensis L.)'. Available at: https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/ Traditional / reference
    https://forest-farming.extension.org/goldenseal-hydrastis-canadensis-l/
  19. Frasca, T. and Brett, A.S. and Yoo, S.D (1997) 'Mandrake toxicity. A case of mistaken identity', Archives of Internal Medicine, 157(17), pp. 2007-9. doi:10.1001/archinte.157.17.2007 Clinical study
    https://doi.org/10.1001/archinte.157.17.2007
  20. North Carolina Extension Gardener Plant Toolbox 'Sanguinaria canadensis (Bloodroot)'. Available at: https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/ Traditional / reference
    https://plants.ces.ncsu.edu/plants/sanguinaria-canadensis/

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.